Global private equity powerhouse KKR is aggressively expanding its footprint in the world’s most populous nation. The buyout giant is in advanced negotiations to acquire a majority stake in the Indian hospital arm of Sweden’s Medicover for at least $1 Billion ($1.05 Billion targeted), marking a massive bet on India’s booming healthcare infrastructure.
The critical metrics and deal architecture behind the transaction:
⚡ The $1.05 Billion Buyout Blueprint
- The Target Stake: Sweden’s parent company, Stockholm-listed Medicover, currently owns 66.9% of Medicover Hospitals India. KKR is gunning to buy out the entire Swedish stake for at least $1.05 Billion while simultaneously holding discussions with minority shareholders.
- The Current Status: A non-binding agreement has officially been reached between the parties, even as Medicover simultaneously keeps an Indian Initial Public Offering (IPO) on the table as a parallel track.
- The Elite Advisory: Financial heavyweights are steering the blockbusting transaction, with Rothschild advising Medicover on the sale and Kotak advising KKR.
🏥 The Massive Infrastructure Scale
- The Network: Having entered the Indian market in 2016, Medicover has built an extensive network operating 26 hospitals boasting approximately 6,000 beds.
- The Revenue Engine: The Indian unit reported a healthy annual revenue of $234.6 Million in 2025. Critically, this Indian operations arm accounts for more than half of Medicover’s entire hospital footprint globally.
📈 India’s Consolidation Rush This transaction cements KKR’s compounding healthcare playbook in India, following its 2024 controlling acquisition of a major hospital chain in Kerala. Driven by surging middle-class incomes, widening health insurance coverage, and an insatiable demand for quality medical infrastructure, India’s hospital sector has become a premier destination for institutional capital. If closed, the deal will heavily weaponize Medicover to go toe-to-toe with local titans like Apollo Hospitals, Aster, and Fortis.